ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

In Brief: Myers, Whang-Peng, Zink Leaving NCU; FDA Hires New Legislative Affairs Chief

February 18, 1994

DCT Board Approves Drug Development Recompetition

November 30, 1990

Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says

August 29, 2008

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981